Droia Invest II SCSp - Jun 22, 2021 Form 4 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role: 10%+ Owner
Signature: Droia Invest II SCSp, By: DF II GP Sarl, By: /s/ Janwillem Naesens, Name: Wepaven BV (represented by Janwillem Naesens), Title: Manager
Stock symbol: CYT
Transactions as of: Jun 22, 2021
Transactions value $: $4,999,986
Form type: 4
Date filed: 6/24/2021, 08:55 PM
Previous filing: Jun 17, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYT	Common Stock	Conversion of derivative security		+3.26M			3.26M	Jun 22, 2021	Direct	F1, F2
transaction	CYT	Common Stock	Purchase	$5M	+278K	+8.52%	$18.00^*	3.54M	Jun 22, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYT	Series B Convertible Preferred Stock	Conversion of derivative security		-10M	-100%		0	Jun 22, 2021	Common Stock	2.93M		Direct	F1, F2
transaction	CYT	Series C Convertible Preferred Stock	Conversion of derivative security		-1.11M	-100%		0	Jun 22, 2021	Common Stock	325K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 3.4088:1 upon completion of the Issuer's initial public offering. The shares have no expiration date.
F2	Shares held by Droia Invest II SCSp. DF II GP Sarl is the general partner of Droia Invest II SCSp. Wepaven BV (represented by Janwillem Naesens) and IHL SA (represented by Luc Verelst), the managers of DF II GP Sarl, share voting and investment power with respect to the shares held of record by Droia Invest II SCSp. Mr. Naesens, a member of the Issuer's board of directors, disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Luc Verelst disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.

Content

Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 3.4088:1 upon completion of the Issuer's initial public offering. The shares have no expiration date.

Shares held by Droia Invest II SCSp. DF II GP Sarl is the general partner of Droia Invest II SCSp. Wepaven BV (represented by Janwillem Naesens) and IHL SA (represented by Luc Verelst), the managers of DF II GP Sarl, share voting and investment power with respect to the shares held of record by Droia Invest II SCSp. Mr. Naesens, a member of the Issuer's board of directors, disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Luc Verelst disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.